logo

Before The Bell

Share

Goldman Sachs Group (GS) reported fourth quarter adjusted EPS of $5.68 Wednesday morning, which topped the consensus estimate of $4.92. Net revenues decreased 4 percent to $7.83 billion from $8.17 billion in the prior year. Analysts expected revenues of $7.61 billion. Goldman Sachs declined during...

Barclays upgraded its rating on shares of IBM Corp. (IBM) Wednesday morning to "Overweight" from "Underweight." IBM gapped open higher Wednesday and advanced further in the early afternoon. The stock finished with a gain of 4.80 at $168.65 on above average volume. IBM has been climbing for the past...

Morgan Stanley downgraded its rating on shares of Dish Network Corp. (DISH) Wednesday morning to "Equal-weight" from "Overweight." Dish Network gapped open lower Wednesday and fell during the first half hour of trade, before settling into a range. The stock closed down by 2.54 at $45.45 with volume...

Fastenal Co. (FAST) reported fourth quarter adjusted EPS of $0.45 Wednesday morning, which was in line with analysts' expectations. Fastenal gapped open lower Wednesday and slid further around mid-morning. The stock ended the day with a loss of 3.24 at $52.20 with volume at a 3-month high. Fastenal...

EXACT Sciences Corp. (EXAS) declined during the first half of the morning Wednesday, but settled into a range for the rest of the session. Shares finished with a loss of 5.27 at $47.68 with volume at an 8-month high. EXACT Sciences dropped below over a 1-month trading range and set a 3-month low....

The Wall Street Journal reported Tuesday that Celgene (CELG) is in talks to acquire Juno Therapeutics Inc. (JUNO). Juno Therapeutics gapped open dramatically higher Wednesday morning, but was range-bound throughout the session. The stock closed up by 23.65 at $69.25 on the highest volume of the year....

Avis Budget Group (CAR) announced Monday that its Board has approved the adoption of a one-year Stockholder Rights Plan. Avis Budget Group declined for the majority of the morning Monday and slipped further around mid-afternoon. Shares finished with a loss of 6.64 at $42.51 on the highest volume...

Eiger BioPharmaceuticals Inc. (EIGR) announced Tuesday morning that its Phase 2 study of ubenimex in pulmonary arterial hypertension demonstrated no improvement for both the primary endpoint of pulmonary vascular resistance and the secondary endpoint of 6-minute walk distance. Eiger BioPharmaceuticals...

Merck & Co. Inc. (MRK) announced Tuesday morning that its Phase 3 trial of KEYTRUDA in combination with pemetrexed and cisplatin or carboplatin, for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer, met its dual primary endpoints of overall survival and progression-free...

UnitedHealth Group Inc. (UNH) reported fourth quarter EPS of $2.59 Tuesday morning, up from $2.11 in the prior year period. Analysts expected EPS of $2.52. Full year 2018 adjusted EPS is expected to be between $12.30 and $12.60. UnitedHealth gapped open higher Tuesday, but was range-bound for the...

Energizer Holdings Inc. (ENR) announced Tuesday morning that it has agreed to acquire Global Battery and Portable Lighting Business from Spectrum Brands Holdings Inc. (SPB) for $2.0 billion in cash. Energizer gapped open sharply higher Tuesday, but traded in a range for the bulk of the session. The...

OSI Systems Inc. (OSIS) announced Tuesday morning that it has signed a new two-year agreement with Servicio de Administración Tributaria which will allow it to continue providing security inspection services in Mexico. OSI Systems gapped open sharply higher Tuesday, but pared its gains in early trade...

Blackhawk Network Holdings (HAWK) announced Tuesday morning that it has agreed to be acquired by Silver Lake and P2 Capital Partners for $3.5 billion in an all-cash transaction. Blackhawk Network gapped open sharply higher Tuesday morning, but moved in a narrow range throughout the session. Shares...

Facebook (FB) said it is making major changes to its News Feed, prioritizing personal posts from family and friends over videos and posts from businesses and news media. In a blog post, co-founder and Chief Executive Mark Zuckerberg said the sweeping changes are being made to "encourage meaningful...

Concert Pharmaceuticals Inc. (CNCE) announced Friday morning that its Post Grant Review petition challenging the validity of U.S. Patent No. 9,662,335 assigned to Incyte Pharmaceuticals has been denied by the U.S. Patent and Trademark Office. The company also announced this morning that it has been...

Follow RTT